HENDERSON JOHN T

Average Profitability
43.23%
Insider Buys Quantity
6
Insider Buys Sum
$647,612.50
Insider Sells Quantity
20
Insider Sells Sum
$9.47M

Insider Activity of HENDERSON JOHN T

According to the SEC Form 4 filings, HENDERSON JOHN T, being in a position of

  1. director at Cytokinetics, Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 22342 shares for $1.58M,
    over all time since 2019-11-19, has bought 6000 shares for $51,427, and sold 65319 shares for $3.52M.

The largest purchase of all time was on 2019-11-07 and amounted to 14000 shares of Myriad Genetics, Inc. for $328,446.

The largest sale of all time was on 2018-07-11 and amounted to 40000 shares of Myriad Genetics, Inc. for $1.51M.

Biography of HENDERSON JOHN T

No biography is available at this moment.

2024-12-11SaleCytokinetics, Incorporated
CYTK
director
1,780
0.0015%
$50.42$89,748-3.53%
2024-04-25SaleCytokinetics, Incorporated
CYTK
director
10,562
0.0099%
$64.54$681,671-15.97%
2024-02-14SaleCytokinetics, Incorporated
CYTK
director
5,000
0.0049%
$76.48$382,400-26.56%
2024-01-12SaleCytokinetics, Incorporated
CYTK
director
5,000
0.0051%
$85.14$425,700-33.31%
2023-12-18SaleCytokinetics, Incorporated
CYTK
director
2,458
0.0025%
$36.34$89,324+57.71%
2023-05-15SaleCytokinetics, Incorporated
CYTK
director
4,166
0.0042%
$37.77$157,350-6.75%
2022-09-12SaleCytokinetics, Incorporated
CYTK
director
21,759
0.0234%
$54.95$1.2M-29.62%
2021-11-05SaleCytokinetics, Incorporated
CYTK
director
8,503
0.0098%
$40.00$340,120-1.9%
2021-04-01SaleCytokinetics, Incorporated
CYTK
director
2,233
0.003%
$23.66$52,833+35.15%
2020-12-31SaleCytokinetics, Incorporated
CYTK
director
858
0.0012%
$20.31$17,426+23.32%
2020-10-05SaleCytokinetics, Incorporated
CYTK
director
3,000
0.0047%
$29.00$87,000-22.61%
2019-11-19PurchaseCytokinetics, Incorporated
CYTK
director
6,000
0.0097%
$8.57$51,427+75.35%
2019-11-07PurchaseMyriad Genetics, Inc.
MYGN
director
14,000
0.0188%
$23.46$328,446-38.53%
2018-07-11SaleMyriad Genetics, Inc.
MYGN
director
40,000
0.0479%
$37.64$1.51M-25.91%
2017-09-01SaleMyriad Genetics, Inc.
MYGN
director
40,000
0.0517%
$26.84$1.07M+13.85%
2017-02-23PurchaseMyriad Genetics, Inc.
MYGN
director
8,000
0.0115%
$18.58$148,634+51.97%
2017-02-22PurchaseMyriad Genetics, Inc.
MYGN
director
4,000
0.0059%
$18.81$75,226+53.56%
2016-09-12SaleMyriad Genetics, Inc.
MYGN
director
4,014
0.0056%
$20.21$81,136-7.52%
2016-09-09SaleMyriad Genetics, Inc.
MYGN
director
55,986
0.0624%
$15.56$870,974-4.68%
2014-06-05SaleMyriad Genetics, Inc.
MYGN
director
10,000
0.0081%
$21.65$216,511+2.2%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.